| CL2467 |
|
1025967-78-5 |
立他司特
Lifitegrast; SAR 1118
3-5days
98+%
|
￥500.00 |
C29H24Cl2N2O7S |
|
|
|
| CLA1358 |
|
1342290-43-0 |
阿利鲁单抗
Abrilumab (Anti-Integrin a4b7 ITGA4 & ITGB7)
3-5days
95+%
|
￥3600.00 |
— |
|
|
|
| CLA1352 |
|
1105038-73-0 |
阿比妥珠单抗
Abituzumab (Anti-Integrin aV / ITGAV / CD51)
3-5days
95+%
|
￥2800.00 |
— |
|
|
|
| CLA1265 |
|
1044758-60-2 |
依曲利组单抗
Etrolizumab (Anti-Integrin α4β7) (ITGA4 & ITGB7)
3-5days
95+%
|
￥6200.00 |
— |
|
|
|
| CLA1226 |
|
339086-79-2 |
罗维珠单抗
Rovelizumab
3-5days
95+%
|
￥3500.00 |
— |
|
|
|
| CLA1211 |
|
211323-03-4 |
厄利珠单抗
Erlizumab (Anti-Integrin b2 / ITGB2 / CD18)
3-5days
95+%
|
￥5500.00 |
— |
|
|
|
| CLA1196 |
|
558480-40-3 |
伏洛昔单抗
Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1))
3-5days
95+%
|
￥3500.00 |
— |
|
|
|
| CLA1185 |
|
892553-42-3 |
埃达组单抗
Etaracizumab
3-5days
95+%
|
￥3000.00 |
— |
|
|
|
| CLA1118 |
|
143653-53-6 |
阿昔单抗
Abciximab
3-5days
95+%
|
￥3000.00 |
— |
|
|
|
| CLA1108 |
|
159445-64-4 |
奥度莫单抗
Odulimomab
3-5days
95+%
|
￥6000.00 |
— |
|
|
|
| CLA1097 |
|
142864-19-5 |
恩莫单抗
Enlimomab
3-5days
95+%
|
￥5200.00 |
— |
|
|
|
| CLA1084 |
|
339086-80-5 |
他度组单抗
Tadocizumab
3-5days
95+%
|
￥5200.00 |
— |
|
|
|
| CLA1062 |
|
214745-43-4 |
依法珠单抗
Anti-Human CD11a Monoclonal Antibody(Efalizumab)
3-5days
95+%
|
￥3000.00 |
— |
|
|
|
| CLA1024 |
|
189261-10-7 |
那他珠单抗
Natalizumab
3-5days
98+%
|
￥2000.00 |
— |
|
|
|
| CLA1011 |
|
943609-66-3 |
维多珠单抗
Vedolizumab
3-5days
98+%
|
￥3000.00 |
— |
|
|
|
